Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Both genetic and lifestyle factors significantly affect female hair loss.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Hair transplantation is the only permanent solution for female pattern hair loss and can greatly improve quality of life with careful planning.

Ancient hair can preserve hormones, revealing health and fertility insights.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Male faces age with more wrinkles and hair loss, influenced by both body changes and environmental factors.

Rasayana therapy can enhance female reproductive health at different life stages.

Women over forty can maintain skin and hair health with lifestyle and dietary changes.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

New drug uses show promise but need more research.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

The document concludes that accurate diagnosis is crucial for effectively treating common scalp disorders, which often have similar symptoms.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Men with sleep apnea and low iron levels are more likely to have male-pattern baldness, especially if they have a family history of hair loss.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.